Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Nice big cup and handle formed ready to break out

<< Previous

Bullboard Posts

Next >>

Comment by FriedChickenon Feb 07, 2021 11:18am

97 Views

Post# 32495607

RE:RE:RE:Nice big cup and handle formed ready to break out

Jeez, you again. Have you figured out the uplisting application processes and timelines yet? You go do that, come back here with your credibility somewhat repaired, then we will chat.

I'd much rather sip on my latte than spending my Sunday morning explaining things to an incurious dimwit. Upon a quick review of 100's of your posts on Stockhouse.....you have had literally nothing of value to contribute or say. It is really quite sad.

Here is a solution.....don't buy any MYCO. There, solved.

Cheers,
FC

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market